Across much of the South and Midwest, the combination of high obesity prevalence, lower wages, and limited insurance coverage creates what could be described as GLP-1 deserts regions where access is constrained not just by price, but by insurance exclusions and state-level policy decisions
But if youre considering these treatments, you likely have one important question: Is GLP-1 safe
Inhibitors or vehicle (DMSO) were added 15 min prior to metformin or AICAR treatment
These concerns are increasingly common in patients who have lost weight rapidly, naturally or with GLP-1 medications
Some people may experience mild gastrointestinal symptoms such as nausea, constipation, or abdominal discomfort, especially at the start of treatment
doi: 10.1146/annurev-pathol-121808-102144 195 MoiseevaODeschnes-SimardXSt-GermainEIgelmannSHuotGCadarAEet al